-The Economic Times NEW DELHI: Top-selling blood pressure drugs and antibiotics could become a lot cheaper as the government plans to notify price caps for 51 essential drugs early next week under a new drug price control order that was enforced last month. Under this second lot of notifications by the National Pharma Pricing Authority, the brands selling the most expensive antibiotics would have to cut their prices by 30-60%. For instance, the...
More »SEARCH RESULT
Prices of key drugs to be cut by up to half-Sushmi Dey
-The Business Standard nppa to soon notify prices in line with new pharma pricing policy Some key cancer drugs, antibiotics and medicines to treat cardiovascular diseases and tuberculosis are set to become cheaper by up to 50 per cent within the next 45 days. The National Pharmaceutical Pricing Authority (nppa) will soon notify prices of as many as 150 packs of essential medicines in line with the new pharma pricing policy, according...
More »Superior packaging can’t be used to raise prices: High Court to Sanofi SA -Maulik Vyas
-The Economic Times MUMBAI: In a setback to Sanofi SA, the Bombay High Court has dismissed the plea filed by the French pharmaceutical major saying 'superior' packaging cannot be the argument for higher pricing of drugs. The court order also clarified that fixing the prices of drugs in the country will remain in the domain of the National Pharmaceutical Pricing Authority. In its argument, the pharmaceutical company had said it had relied...
More »SC’s Novartis judgement renews focus on accessible medicine
The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...
More »New mechanism: price of cancer drugs set to fall -Himani Chandna Gurtoo
-The Hindustan Times Cancer drugs will cost almost 25% less if the regulator implements a new formula that calls for a price cap. The price regulator National Pharmaceutical Pricing Authority (nppa) is considering a pricing mechanism similar to the one for insulin products - which has brought down prices by up to 40% - for 33 cancer drugs, most of them generics. Basically, the lowest price from the list of drugs in a...
More »